Clinical Trial Update: ROSSINI 2 - Reduction of Surgical Site Infection Using Several Novel Interventions [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for ROSSINI 2 evaluating several novel interventions to reduce surgical site infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Surgical Site Infection
• Surgical Wound Infection

Snippet

Sponsor: University of Birmingham | Conditions: Surgical Site Infection, Surgical Wound Infection | Phase 3 | Status: UNKNOWN